Amazing that you seem to think we have better than 50% chance to get FDA approval for covid ards.
#1. You do realize that many phase 3 trials are rejected even though they passed in phase 1 and 2 right? It is really difficult to get FDA approval for phase 3 trial especially for Covid ARDS which will be under so much scrutiny around the world and by so many competitors.
#2. You do realize that ecoool2 has stated 20-30% chance for phase 3 approval for Covid ARDS right? Do yourself a favor and check out his unbiased analysis.
MSB Trading - 2020, page-19289
-
- There are more pages in this discussion • 3,872 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
0.075(5.38%) |
Mkt cap ! $1.684B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.50 | $1.40 | $4.800M | 3.328M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 18948 | $1.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 232 | 2 |
View Market Depth
| Last trade - 14.26pm 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |